The Moat Index

GeneDx Holdings Corp.

WGS · Healthcare · $1.9B mkt cap · FY2025 filings · No moat ·

Doesn't clear the bar

33/ 100
No moat

The four filters

Pricing power42

Median gross margin 42.2% over 7y, variable.

Returns on capital0

Median ROIC -43.6%, above the 9% hurdle in 0% of years.

Balance-sheet safety55

Net cash position — no leverage risk.

Capital discipline44

Owner earnings trend unclear, share count n/a.

Margin of safety

Above valueOn sale
No price data
Owner earnings (normalized)
Est. intrinsic value / share
Recent price
$63.48
Discount to value
No price data

Conservative model: 9% discount rate, 0% assumed growth (capped at 4%), maintenance capex ≈ min(capex, D&A).

8 years of fundamentals

The business, in plain English

GeneDx Holdings Corp. booked $427.5M of revenue in FY2025 in the Healthcare sector and kept 69.7% of it as gross profit — a high-margin business by that measure. After every other cost, −4.9% of each revenue dollar reached the bottom line.

Across the filed record, revenue grew from $196.2M (FY2019) to $427.5M (FY2025) — about 13.9% a year compounded over 6 years.

It earned −4.0% on invested capital in FY2025, with a median of −43.6% across 4 filed years. The Returns on Capital filter above scores it 0/100.

The balance sheet carried $52.7M of total debt in FY2025. Balance-Sheet Safety scores it 55/100.

Put together: Balance-Sheet Safety is the strongest of the four filters (55/100) and Returns on Capital the weakest (0/100), which is how WGS lands at 33/100 — a None moat.

This breakdown is generated from the filed numbers and sub-scores above — no outside narrative, no estimates. Where a filing doesn’t disclose an input, the sentence that would need it is omitted instead of guessed.

FY2018–FY2025 · 8 fiscal years, normalized from WGS’s SEC filings

RevenueSales, as filed$427.5M FY2025
$0$200M$400M201820212025
Gross marginRevenue kept after cost of goods69.7% FY2025
0%50%201820212025
Return on invested capitalOperating profit on the capital employed−4.0% FY2025
−400%−200%0%201820212025
Owner earningsCash an owner could take out−$21.0M FY2025
−$400M−$200M$0201820212025

Gaps in a line mean that item isn’t in WGS’s filings for that year — the series is never interpolated or estimated. The Table view lists every filed value, including operating and net margins, total debt, and share count.

Moat Score history

3 logged readings since Jul 17, 2026 · append-only, never rewritten

Moat Score over timeLast scored reading of each day, on the 0–100 scale32.5 / 100
0406080100WideNarrowShallowNo moatJul 17, 2026

Score history begins Jul 17, 2026 — the record builds from here and can’t be backfilled.

Tier changesSame-methodology crossings of the Wide / Narrow / Shallow bars

None yet — WGS has read No moat for every logged capture since Jul 17, 2026.

Scores are logged append-only and never overwritten — this record can’t be backfilled, which is exactly why it’s worth keeping.

Healthcare context

#331 of 440 scored Healthcare companies, ranked by Moat Score.

Nearest peers by Moat Score

  1. #329ETON Eton Pharmaceuticals, Inc.32.8 out of 100, No moatNo moat
  2. #330PRCT PROCEPT BioRobotics Corporation32.5 out of 100, No moatNo moat
  3. #332AVTR Avantor, Inc.32.3 out of 100, No moatNo moat
  4. #333CATX PERSPECTIVE THERAPEUTICS, INC.32.2 out of 100, No moatNo moat

Compare WGS with its nearest peersAll Healthcare companies on the Index →

Common questions about WGS

Does GeneDx Holdings Corp. have an economic moat?
Based on its FY2025 SEC filings, the Moat Index scores GeneDx Holdings Corp. (WGS) 32.5 out of 100 — below the Shallow-moat bar, so no moat. The four filters behind that score (each 0–100): pricing power 42, returns on capital 0, balance-sheet safety 55, capital discipline 44.
How has WGS's Moat Score changed over time?
The record logs 3 readings since Jul 17, 2026; the latest reads 32.5 out of 100 (no moat). No tier changes on record yet. The history is append-only — readings are only ever added, never rewritten.
Embed this score on your site

One iframe, no script. The badge shows WGS’s live Moat Score, updates itself as new filings are scored, and links back here. How it works.

<iframe
  src="https://buylikebuffett.com/embed/WGS"
  width="340" height="150" style="border:0"
  title="WGS Moat Score — The Moat Index"
  loading="lazy"></iframe>
GeneDx Holdings Corp. (WGS) Moat Score — The Moat Index · Buy Like Buffett